Alternative Data for Guardant Health
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 95 | Sign up | Sign up | Sign up |
| Sentiment | 93 | Sign up | Sign up | Sign up |
| Webpage traffic | 64,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 130 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,820 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 12 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 4,918 | Sign up | Sign up | Sign up |
| X Followers | 6,469 | Sign up | Sign up | Sign up |
| X Mentions | 8 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 851 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Lobbying Cost | $247,000 | Sign up | Sign up | Sign up |
| Business Outlook | 56 | Sign up | Sign up | Sign up |
| Linkedin Employees | 4,248 | Sign up | Sign up | Sign up |
About Guardant Health
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally.
| Price | $85.49 |
| Target Price | Sign up |
| Volume | 1,712,244 |
| Market Cap | $11.2B |
| Year Range | $40.98 - $117.28 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
New Blood Test for Colon Cancer Screening: Shield™ from Guardant HealthMarch 2 - Thefocalpoints.com |
Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics AcquisitionMarch 1 - Yahoo Entertainment |
|
Piper Sandler Maintains Overweight on Guardant Health, Raises Price Target to $130February 23 - Benzinga |
|
 |
Guardant Health price target raised by $10 at JPMorganFebruary 20 - Thefly.com |
Leerink Partners Maintains Outperform on Guardant Health, Raises Price Target to $180February 20 - Benzinga |
|
Citigroup Maintains Buy on Guardant Health, Raises Price Target to $150February 20 - Benzinga |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 265M | 94M | 172M | -93M | -82M | -0.390 |
| Q2 '25 | 232M | 81M | 151M | -100M | -89M | -0.440 |
| Q1 '25 | 203M | 75M | 129M | -95M | -84M | -0.490 |
| Q4 '24 | 202M | 78M | 124M | -111M | -99M | -0.620 |
| Q3 '24 | 191M | 74M | 117M | -108M | -96M | -0.880 |
Insider Transactions View All
| Hidalgo Medina Manuel filed to sell 1,193 shares at $91.3. March 9 '26 |
| Hidalgo Medina Manuel filed to sell 1,493 shares at $91.6. March 9 '26 |
| Kalia Kumud filed to sell 37,643 shares at $95.7. March 5 '26 |
| Kalia Kumud filed to sell 50,663 shares at $95.1. March 5 '26 |
| Monroe Terilyn J. filed to sell 27,858 shares at $112.3. January 22 '26 |
Similar companies
Read more about Guardant Health (GH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Guardant Health
The Market Cap of Guardant Health is $11.2B.
Currently, the price of one share of Guardant Health stock is $85.49.
The GH stock price chart above provides a comprehensive visual representation of Guardant Health's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Guardant Health shares. Our platform offers an up-to-date GH stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Guardant Health (GH) does not offer dividends to its shareholders. Investors interested in Guardant Health should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Guardant Health are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
